US equities
|
NVDA
$236.97
▲+1.29%
SPCX
$166.99
▲+5.05%
MU
$1,064.69
▼-0.95%
TSLA
$376.70
▲+1.65%
MSFT
$527.05
▲+1.84%
INTC
$117.41
▼-1.61%
SNDK
$1,726.73
▲+0.39%
META
$744.00
▲+2.19%
NVDA
$236.97
▲+1.29%
SPCX
$166.99
▲+5.05%
MU
$1,064.69
▼-0.95%
TSLA
$376.70
▲+1.65%
MSFT
$527.05
▲+1.84%
INTC
$117.41
▼-1.61%
SNDK
$1,726.73
▲+0.39%
META
$744.00
▲+2.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
aTyr Pharma, Inc. - Common Stock
(NQ:
ATYR
)
0.2815
-0.0057 (-1.98%)
Delayed Quote
Updated: 10:24 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about aTyr Pharma, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR
November 20, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR
November 20, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Levi & Korsinsky Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR
November 19, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Levi & Korsinsky Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR
November 19, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Levi & Korsinsky Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR
November 18, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Levi & Korsinsky Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR
November 18, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR
November 17, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Stockholders of aTyr, Marex, Cepton, and MoonLake to Contact the Firm About their Rights Before Upcoming Deadlines
November 17, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
November 17, 2025
From
Schall Law
Via
GlobeNewswire
aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ATYR
November 17, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ATYR
November 17, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
10 Health Care Stocks With Whale Alerts In Today's Session
↗
November 14, 2025
Via
Benzinga
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
November 14, 2025
From
Schall Law
Via
GlobeNewswire
ATYR Investors: Securities Law Firm Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the Class Action Against aTyr Pharma, Inc.
November 12, 2025
From
Robbins LLP
Via
GlobeNewswire
Contact Levi & Korsinsky by December 8, 2025 Deadline to Join Class Action Against aTyr Pharma, Inc. (ATYR)
November 12, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Contact Levi & Korsinsky by December 8, 2025 Deadline to Join Class Action Against aTyr Pharma, Inc. (ATYR)
November 12, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR
November 11, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors of aTyr, Marex, Cepton, and MoonLake to Contact the Firm About their Rights in Filed Class Action Lawsuits
November 11, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
November 11, 2025
From
Schall Law
Via
GlobeNewswire
Class Action Filed Against aTyr Pharma, Inc. (ATYR) Seeking Recovery for Investors - Contact Levi & Korsinsky
November 11, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Class Action Filed Against aTyr Pharma, Inc. (ATYR) Seeking Recovery for Investors - Contact Levi & Korsinsky
November 11, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ATYR
November 10, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ATYR
November 10, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
ATYR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that aTyr Pharma Investors Have Opportunity to Lead Class Action Lawsuit
November 09, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
November 07, 2025
From
Schall Law
Via
GlobeNewswire
Levi & Korsinsky Reminds aTyr Pharma, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 8, 2025 - ATYR
November 07, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Levi & Korsinsky Reminds aTyr Pharma, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 8, 2025 - ATYR
November 07, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
ATYR PHARMA INC (NASDAQ:ATYR) Shares Slide After Q3 Revenue and EPS Miss Estimates
↗
November 06, 2025
aTyr Pharma's Q3 2025 results missed revenue and EPS estimates. Investors now focus on the upcoming 2026 FDA meeting for its lead drug, efzofitimod.
Via
Chartmill
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at aTyr Pharma
November 06, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
Levi & Korsinsky Reminds aTyr Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 8, 2025 - ATYR
November 06, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
< Previous
1
2
3
4
5
6
Next >
